Fogarty Institute for Innovation At the Forefront of Reinvention of Women's Healthcare
– Two of its entrepreneurs among a select group of women recognized in Forbes' prestigious "30 Under 30" list –
MOUNTAIN VIEW, Calif., February 4, 2015 – The Forbes annual "30 Under 30" list identifies the best and brightest, and the Fogarty Institute for Innovation (FII), a nonprofit that provides intellectual, physical and financial resources to medical startups, is proud to house two of the honorees. Jessie Becker, co-founder and CEO of InPress Technologies was recognized in 2015 and Surbhi Sarna, founder and CEO of nVision Medical, made the list in 2014. Both women were among a handpicked group of entrepreneurs recognized for shaping the future of healthcare.
InPress is developing a simple device that is intended to quickly and effectively stop postpartum hemorrhage (PPH), the leading cause of maternal death globally, taking the life of one woman every four minutes. Early results of the company's clinical trial in Jakarta, Indonesia, have been 100 percent successful. The company has already raised $1.5 million in seed money.
nVision is an early-stage, venture-backed medical device company that is dedicated to filling the void in female health-related innovation. They are currently developing catheter-based diagnostic devices for non-invasive cell retrieval, as well as for detection of fallopian tube blockage – the leading cause of infertility in women. nVision raised a venture led Series A of $4.5M in May of 2013 and will engage with the FDA this year.
"We are energized by the progress in medical device innovation made by our early-stage companies, and it is a great distinction that two of our entrepreneurs have been chosen by Forbes for their pioneering role in advancing healthcare," said Anne Fyfe, President and CEO of the Fogarty Institute for Innovation. "Both of these young women are very deserving of the Forbes recognition and we look forward to continue championing medical innovation for the unmet needs of women and newborns."
About The Fogarty Institute for Innovation
The Fogarty Institute for Innovation is a 501(c)(3) non-profit that helps early-stage medical companies transform their ideas into better patient care. A group of select medical innovators are offered office space, research and development resources, financial aid, and world-class mentoring by volunteer physicians to bring their product to market. The Institute was founded in 2007 by internationally renowned cardiovascular surgeon and innovator Dr. Thomas J. Fogarty, M.D., and it is based on the El Camino Hospital campus in Mountain View, Calif. The organization has successfully launched three companies in the past six years. To learn more, visit www.fogartyinstitute.org.